-
Signature
-
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact
-
Stock symbol
-
LEVI
-
Transactions as of
-
Nov 14, 2023
-
Transactions value $
-
-$512,639
-
Form type
-
4
-
Date filed
-
11/16/2023, 04:45 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
LEVI |
Class A Common Stock |
Conversion of derivative security |
$0 |
+17.1K |
+17.6% |
$0.00 |
114K |
Nov 14, 2023 |
Direct |
F1, F2 |
transaction |
LEVI |
Class A Common Stock |
Sale |
-$257K |
-17.1K |
-14.97% |
$15.00 |
97.2K |
Nov 14, 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
LEVI |
Stock Appreciation Rights |
Options Exercise |
$0 |
-63.3K |
-100% |
$0.00* |
0 |
Nov 14, 2023 |
Class B Common Stock |
63.3K |
$6.90 |
Direct |
F1, F4, F5 |
transaction |
LEVI |
Class B Common Stock |
Options Exercise |
$437K |
+63.3K |
+2293.22% |
$6.90 |
66.1K |
Nov 14, 2023 |
Class A Common Stock |
63.3K |
|
Direct |
F1, F5 |
transaction |
LEVI |
Class B Common Stock |
Disposed to Issuer |
-$693K |
-46.2K |
-69.92% |
$15.00 |
19.9K |
Nov 14, 2023 |
Class A Common Stock |
46.2K |
|
Direct |
F1, F5, F6 |
transaction |
LEVI |
Class B Common Stock |
Conversion of derivative security |
$0 |
-17.1K |
-86.11% |
$0.00 |
2.76K |
Nov 14, 2023 |
Class A Common Stock |
17.1K |
|
Direct |
F1, F2, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: